News Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Market Closed - Nyse Other stock markets 16:00:02 2025-12-04 EST			After hours 16:31:55
100.89 ^USD	-1.35%		100.73	-0.16%

03:45pm	Halozyme Granted Injunction Against Merck & Co. in Germany in Keytruda Patent Case -- Update	DJ
03:44pm	Halozyme Wins German Patent Injunction Blocking Merck's Subcutaneous Keytruda	MT

Halozyme Granted Injunction Against Merck & Co. in Germany in Keytruda Patent Case -- Update	03:45pm	DJ
Halozyme Wins German Patent Injunction Blocking Merck's Subcutaneous Keytruda	03:44pm	MT
Correction to Halozyme Granted Injunction Against Merck & Co. Article	03:22pm	DJ
Halozyme Granted Injunction Against Merck & Co. in Germany in Keytruda Patent Case	02:24pm	DJ
Halozyme wins preliminary injunction against Merck's Keytruda SC in Germany	01:31pm	RE
Merck says Exzolt Cattle-CA1 to be available by prescription in Q1 2026	01:08pm	RE
Merck Gets Conditional FDA Approval for Cattle Antiparasitic	12:46pm	DJ
Merck Animal Heath Gets FDA Conditional Approval for Exzolt Cattle-CA1	12:42pm	MT
FDA Conditionally Approves Merck Animal Health's EXZOLT™ CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis)	12:05pm	BU
FDA conditionally approves topical drug for cattle against New World screwworm, fever tick	12:00pm	RE
Women can self-test at home for cervical cancer virus, new guidelines say	10:19am	RE
Scotiabank Adjusts Price Target on Merck & Co to $120 From $105, Maintains Sector Outperform Rating	07:51am	MT
Kennedy advisers delay vote to drop hepatitis B vaccine recommendation, a major policy shift	06:07am	RE
Trump 'garbage' rhetoric about Somalis draws cheers from administration, silence from Republicans and alarm from critics	06:06am	RE
Formycon Secures First Marketing Partnership for Keytruda Biosimilar	02:27am	DP
Merck & Co., Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-03-2025 01:00 PM	12-03
Merck & Co., Inc. Presents at Evercore 8th Annual Healthcare Conference, Dec-02-2025 09:10 AM	12-02
Zero-tariff deal with US to cost NHS GBP1 billion, No 10 says	12-02	AN
Ready or Not It's Coming	12-02
Merck & Co files for seven-part notes offering of up to $7.5 billion - SEC filing	12-02	RE
Antengene announces IND approval in China for phase Ib/II study of ATG-022 in combination with Keytruda	12-02	RE
TREASURIES-US bonds slide as selling in Japan spills over; Merck deal weighs on market	12-01	RE
Sector Update: Health Care Stocks Decline Late Afternoon	12-01	MT
Sector Update: Health Care Stocks Decline Monday Afternoon	12-01	MT
US to zero out tariffs on UK pharmaceuticals under trade deal	12-01	AN

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Merck to Buy Verona Pharma for About $10B

July 09, 2025 at 12:30 pm